Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 150

Sort by

Sort Order Select

Journal Articles

Single-cell transcriptional profiling identifies ADGRG1+ CD8 T cells as critical mediators of graft-versus-leukemia effect in AML relapse after haploidentical hematopoietic stem cell transplantation

Panpan Zhu, Luxin Yang, Yibo Wu, Xiaolin Yuan, Lizhen Liu, Xiaoyu Lai, He Huang, Shanshan Pei, Hezhou Guo, Yi Luo

Blood (2025) 146 (Supplement 1): 5870.

https://doi.org/10.1182/blood-2025-5870

Published: 2025

Journal Articles

Machine learning using bayesian networks to predict response in patients with newly diagnosed Acute Myeloid Leukemia

Onyee Chan, Najla Al Ali, Seongseok Yun, David Sallman, Eric Padron, Alison Walker, Rami Komrokji, Gilmer Valdes, Jeffrey Lancet, Issam El Naqa, Yi Luo

Blood (2025) 146 (Supplement 1): 4357.

https://doi.org/10.1182/blood-2025-4357

Published: 2025

Journal Articles

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Blood (2025) 146 (Supplement 1): 2523.

https://doi.org/10.1182/blood-2025-2523

Published: 2025

Journal Articles

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation.

Bingqian Jiang, Jian Yu, Yanmin Zhao, Yi Luo, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Congxiao Zhang, Yi Yu, Guanfang Zhang, He Huang, Jimin Shi

Blood (2025) 146 (Supplement 1): 2426.

https://doi.org/10.1182/blood-2025-2426

Published: 2025

Journal Articles

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Jia Hu, Jingyi Huang, Wei Bian, Xiaoqing Zou, Yuanyuan Zhu, Weijia Huang, Yue Liang, Yi Zhao, Weiyan Zheng, Lixia Zhu, Xiu-Jin Ye, Yi Luo, Jimin Shi, Zhen Cai, He Huang, Shanshan Pei, Jie Sun

Blood (2025) 146 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2025-1508

Published: 2025

Journal Articles

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Yanmin Zhao, Yeqian Zhao, Shanshan Pei, Jimin Shi, Yi Luo, Jie Sun, Weiyan Zheng, Wenjun Wu, Yi Zhao, Lixia Zhu, Jian Yu, Lizhen Liu, Xiaoyu Lai, Huarui Fu, He Huang, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2025-3404

Published: 2025

Journal Articles

Azacitidine combined with Venetoclax for pre-emptive treatment of AML/MDS after allogeneic stem cell transplantation: A prospective phase II study

Lizhen Liu, Shipei Xiang, Xiaoyu Lai, Luxin Yang, Yibo Wu, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yishan Ye, Panpan Zhu, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 1061.

https://doi.org/10.1182/blood-2025-1061

Published: 2025

Journal Articles

Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.

Blood (2025) 146 (Supplement 1): 1059.

https://doi.org/10.1182/blood-2025-1059

Published: 2025

Journal Articles

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory chronic graft-versus-host disease

Yibo Wu, Lizhen Liu, Yi Chen, Xiaoyu Lai, Ying Lu, Luxin Yang, Lin Li, Lan Sun, Junjie Cao, Jimin Shi, Xiaolin Yuan, Panpan Zhu, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 7761.

https://doi.org/10.1182/blood-2025-7761

Published: 2025

Journal Articles

A scoring system for epstein-barr reativation after hematopoietic stem cell transplantation

Xinyu Wang, Yanmin Zhao, Jingsong He, Yi Luo, He Huang, Jimin Shi

Blood (2025) 146 (Supplement 1): 7811.

https://doi.org/10.1182/blood-2025-7811

Published: 2025

Journal Articles

Inotuzumab ozogamicin as salvage therapy for refractory/relapsed B-cell acute lymphoblastic leukemia following the failure of chimeric antigen receptor T cell therapy and allogeneic hematopoietic stem cell transplantation

Honghu Li, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Lixia Zhu, Kui zhao, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 7810.

https://doi.org/10.1182/blood-2025-7810

Published: 2025

Journal Articles

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Blood (2025) 146 (Supplement 1): 5209.

https://doi.org/10.1182/blood-2025-5209

Published: 2025

Journal Articles

Low-dose chidamide maintenance therapy following allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukemia or lymphoma: A phase 2, open-label, multicenter, single-arm trial

Yi Yu, Weihao Chen, Jimin Shi, Yi Luo, Jian Yu, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Guifang Ouyang, He Huang, Lixia Sheng, Weijie Cao, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 169.

https://doi.org/10.1182/blood-2025-169

Published: 2025

Journal Articles

Allo-HCT outcomes for AML patients with NUP98 rearrangements: A study on behalf of the global committee, the ALWP and the PDWP of the EBMT

Blood (2025) 146 (Supplement 1): 4270.

https://doi.org/10.1182/blood-2025-4270

Published: 2025

Journal Articles

Incidence and risk factors of Epstein–Barr virus reactivation and post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: A 985-patient retrospective cohort analysis

Fei Gao, Xinyu Wang, Yi Luo, Jian Yu, Huarui Fu, Xiaoyu Lai, Lizhen Liu, He Huang, Jimin Shi, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 4280.

https://doi.org/10.1182/blood-2025-4280

Published: 2025

Journal Articles

A first-in-human study of CT0596, an allogeneic CAR T-cell therapy targeting BCMA, in patients with relapsed/refractory multiple myeloma

Juan Du, Lina Jin, Wanting Qiang, Pei Guo, Haiyan He, Xiaoqiang Fan, Xinying Zhao, Daijing Yuan, Yi Luo, Zonghai LI

Blood (2025) 146 (Supplement 1): 2296.

https://doi.org/10.1182/blood-2025-2296

Published: 2025

Journal Articles

High HLA evolutionary divergence mismatch increases the risk of acute graft-versus-host disease and mortality after haploidentical hematopoietic stem cell transplantation

Ce Shi, Xiangjun Zeng, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, He Huang, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 584.

https://doi.org/10.1182/blood-2025-584

Published: 2025

Journal Articles

Plasma proteomic profiles predict future non-Hodgkin lymphoma in healthy adults

Qing Luo, Yi Luo, Li Yu

Blood (2025) 146 (Supplement 1): 5334.

https://doi.org/10.1182/blood-2025-5334

Published: 2025

Journal Articles

A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD

Blood (2025) 145 (24): 2857–2872.

https://doi.org/10.1182/blood.2024026581

Published: 2025

Includes: Supplemental data

Journal Articles

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Blood (2024) 144 (Supplement 1): 7420.

https://doi.org/10.1182/blood-2024-209418

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Single-cell transcriptional profiling identifies ADGRG1+ CD8 T cells as critical mediators of graft-versus-leukemia effect in AML relapse after haploidentical hematopoietic stem cell transplantation

Machine learning using bayesian networks to predict response in patients with newly diagnosed Acute Myeloid Leukemia

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation.

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Azacitidine combined with Venetoclax for pre-emptive treatment of AML/MDS after allogeneic stem cell transplantation: A prospective phase II study

Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory chronic graft-versus-host disease

A scoring system for epstein-barr reativation after hematopoietic stem cell transplantation

Inotuzumab ozogamicin as salvage therapy for refractory/relapsed B-cell acute lymphoblastic leukemia following the failure of chimeric antigen receptor T cell therapy and allogeneic hematopoietic stem cell transplantation

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Low-dose chidamide maintenance therapy following allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukemia or lymphoma: A phase 2, open-label, multicenter, single-arm trial

Allo-HCT outcomes for AML patients with NUP98 rearrangements: A study on behalf of the global committee, the ALWP and the PDWP of the EBMT

Incidence and risk factors of Epstein–Barr virus reactivation and post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: A 985-patient retrospective cohort analysis

A first-in-human study of CT0596, an allogeneic CAR T-cell therapy targeting BCMA, in patients with relapsed/refractory multiple myeloma

High HLA evolutionary divergence mismatch increases the risk of acute graft-versus-host disease and mortality after haploidentical hematopoietic stem cell transplantation

Plasma proteomic profiles predict future non-Hodgkin lymphoma in healthy adults

A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only